Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: Current situation and future development

Zhaoxiang BIAN*, Baoyan Liu, David Moher, Taixiang Wu, Youping Li, Hongcai Shang, Chungwah Cheng

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

53 Citations (Scopus)

Abstract

The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.

Original languageEnglish
Pages (from-to)171-177
Number of pages7
JournalFrontiers of Medicine in China
Volume5
Issue number2
DOIs
Publication statusPublished - Jun 2011

Scopus Subject Areas

  • Medicine(all)

User-Defined Keywords

  • CONSORT for TCM
  • Future development
  • Reporting standards

Fingerprint

Dive into the research topics of 'Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: Current situation and future development'. Together they form a unique fingerprint.

Cite this